NCT03687463View on ClinicalTrials.gov

Modified Post-Transplant Cyclophosphamide Regimen for Children With Juvenile Myelomonocytic Leukemia

UnknownOBSERVATIONAL
Enrollment

6

Participants

Timeline

Start Date

April 10, 2015

Primary Completion Date

July 10, 2018

Study Completion Date

April 10, 2020

Conditions
Hematopoietic System--Cancer
Interventions
DRUG

Decitabine

Decitabine for injection

Sponsors
All Listed Sponsors
lead

Capital Research Institute of Pediatrics

OTHER_GOV